Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M75.4Revenue (TTM) $M--Net Margin (%)--Altman Z-Score-0.4
Enterprise Value $M-5.0EPS (TTM) $-2.5Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book0.910-y EBITDA Growth Rate %--Quick Ratio6.2Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio6.2Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-46.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-52.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M23.7ROIC % (ttm)-249.5Gross Margin Increase y-yN

Gurus Latest Trades with LIFE

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LIFEMario Gabelli 2014-03-31 Sold Out -0.47%$75.75 - $76.07
($75.91)
$ 3.18-96%Sold Out0
LIFEJohn Paulson 2014-03-31 Sold Out -0.03%$75.75 - $76.07
($75.91)
$ 3.18-96%Sold Out0
LIFEJoel Greenblatt 2014-03-31 Sold Out -0.03%$75.75 - $76.07
($75.91)
$ 3.18-96%Sold Out0
LIFEJohn Paulson 2013-12-31 Reduce-0.04%$74.72 - $75.78
($75.43)
$ 3.18-96%Reduce -50.48%89,657
LIFEFirst Eagle Investment 2013-12-31 Reduce-0.03%$74.72 - $75.78
($75.43)
$ 3.18-96%Reduce -63.70%72,600
LIFEJoel Greenblatt 2013-12-31 Add0.02%$74.72 - $75.78
($75.43)
$ 3.18-96%Add 320.36%14,885
LIFEJohn Paulson 2013-09-30 Reduce-0.58%$74.06 - $74.96
($74.61)
$ 3.18-96%Reduce -85.90%181,053
LIFEFirst Eagle Investment 2013-09-30 Reduce-0.06%$74.06 - $74.96
($74.61)
$ 3.18-96%Reduce -56.11%200,000
LIFEJoel Greenblatt 2013-09-30 Reduce-0.02%$74.06 - $74.96
($74.61)
$ 3.18-96%Reduce -67.32%3,541
LIFEJohn Paulson 2013-06-30 Reduce-4.93%$64.57 - $74.41
($72.6)
$ 3.18-96%Reduce -91.31%1,284,433
LIFEJohn Rogers 2013-06-30 Sold Out -1.9%$64.57 - $74.41
($72.6)
$ 3.18-96%Sold Out0
LIFERobert Olstein 2013-06-30 Sold Out -1.1%$64.57 - $74.41
($72.6)
$ 3.18-96%Sold Out0
LIFEMeridian Funds 2013-06-30 Sold Out -0.83%$64.57 - $74.41
($72.6)
$ 3.18-96%Sold Out0
LIFERonald Muhlenkamp 2013-06-30 Sold Out -0.67%$64.57 - $74.41
($72.6)
$ 3.18-96%Sold Out0
LIFEMario Gabelli 2013-06-30 Add0.59%$64.57 - $74.41
($72.6)
$ 3.18-96%Add 3187.35%1,311,520
LIFEFirst Eagle Investment 2013-06-30 Buy 0.1%$64.57 - $74.41
($72.6)
$ 3.18-96%New holding455,735
LIFEJoel Greenblatt 2013-06-30 Reduce-0.02%$64.57 - $74.41
($72.6)
$ 3.18-96%Reduce -33.08%10,836
LIFERonald Muhlenkamp 2013-03-31 Reduce-1.77%$49.03 - $65.27
($60.09)
$ 3.18-95%Reduce -76.85%50,000
LIFERobert Olstein 2013-03-31 Reduce-0.62%$49.03 - $65.27
($60.09)
$ 3.18-95%Reduce -38.51%99,000
LIFEJohn Paulson 2013-03-31 Add0.28%$49.03 - $65.27
($60.09)
$ 3.18-95%Add 5.53%14,773,700
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LIFE is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


LIFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Matsuoka GroveSee Remarks 2016-05-11Buy12,412$3.044.61view
SCHIMMEL PAULDirector 2016-04-14Buy66,219$4.18-23.92view
SCHIMMEL PAULDirector 2016-04-13Buy9,835$3.85-17.4view
SCHIMMEL PAULDirector 2016-04-12Buy9,127$3.71-14.29view
SCHIMMEL PAULDirector 2016-04-11Buy32,659$3.57-10.92view
SCHIMMEL PAULDirector 2016-04-11Buy32,659$3.57-10.92view
SCHIMMEL PAULDirector 2016-04-08Buy85,000$3.22-1.24view
SCHIMMEL PAULDirector 2016-04-07Buy40,000$3.19-0.31view
SCHIMMEL PAULDirector 2016-04-06Buy25,000$3.2-0.63view
MENDLEIN JOHNCEO and Director 2016-04-05Buy2,500$3.55-10.42view

Press Releases about LIFE :

Quarterly/Annual Reports about LIFE:

News about LIFE:

Articles On GuruFocus.com
No related article found.

More From Other Websites
Gershman of aTyr Pharma to Speak on Muscular Dystrophy (LIFE) Sep 29 2016
aTyr Pharma Announces Presentation at the 21st International Annual Congress of the World Muscle... Sep 29 2016
aTyr Pharma Appoints Industry Veteran in Novel Biology Biologics, David J. King, PhD, as Senior Vice... Sep 21 2016
aTyr Pharma Appoints Industry Veteran in Novel Biology Biologics, David J. King, PhD, as Senior Vice... Sep 21 2016
7 Stocks Under $10 Making Big Moves Higher Sep 15 2016
ATYR PHARMA INC Financials Aug 19 2016
ATYR PHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 10 2016
Atyr Pharma reports 2Q loss Aug 10 2016
Atyr Pharma reports 2Q loss Aug 10 2016
aTyr Pharma Announces Second Quarter 2016 Operating Results Aug 10 2016
aTyr Pharma Announces Second Quarter 2016 Operating Results Aug 10 2016
ATYR PHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers Jun 16 2016
aTyr Pharma, Inc. :LIFE-US: Earnings Analysis: Q1, 2016 By the Numbers : June 10, 2016 Jun 10 2016
aTyr Pharma to Present at Jefferies 2016 Healthcare Conference Jun 03 2016
aTyr Pharma to Present at Jefferies 2016 Healthcare Conference Jun 03 2016
ATYR PHARMA INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 26 2016
aTyr Pharma Announces First Quarter 2016 Operating Results May 11 2016
Atyr Pharma reports 1Q loss May 11 2016
Atyr Pharma reports 1Q loss May 11 2016
ATYR PHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... May 11 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)